IMRA - IMARA Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
15.90
-0.10 (-0.63%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close16.00
Open15.88
Bid15.75 x 1100
Ask15.99 x 800
Day's Range15.76 - 16.13
52 Week Range13.40 - 17.50
Volume1,163
Avg. Volume81,383
Market Cap263.55M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • IMARA Announces Pricing of Initial Public Offering
    GlobeNewswire

    IMARA Announces Pricing of Initial Public Offering

    IMARA Inc. (the “Company”) (IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, known as hemoglobinopathies, announced the pricing of its initial public offering of 4,700,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $75.2 million, before underwriting discounts and commissions and offering expenses payable by the Company. In addition, the Company has granted the underwriters an option for a period of 30 days to purchase up to 705,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions.